Authors

  • Rakhmonova G.E., Rahmanova M.D.

Keywords:

prenatal, postnatal, fetal echocardiography, congenital heart disease, transthoracic, ultrasound.

References

1. Abman SH, Hansmann G, Archer SL, et al. Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society. Circulation. 2015; 132(21): 2037–2099. doi:10.1161/CIR.0000000000000329

2. Allan LD, Sharland GK. Milestones in the development of fetal echocardiography. Prenatal Diagnosis. 2015;35(13):1304–1308. doi:10.1002/pd.4603

3. Arnaout R, Curran L, Chinn E, et al. An artificial intelligence–based model for the diagnosis of congenital heart disease from transthoracic echocardiography. Nature Medicine. 2021;27(9):1641–1651. doi:10.1038/s41591-021-01447-3

4. Atzei A, Gau G, Bhatt D, et al. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Ultrasound in Obstetrics and Gynecology. 2022; 60(5):634–641. doi:10.1002/uog.24924

5. Aybek S, Ozaslan S, Gocer H, et al. Three-dimensional echocardiography in congenital heart disease surgical planning. European Heart Journal – Cardiovascular Imaging. 2019;20(8):871–879. doi:10.1093/ehjci/jez044

6. Bhatt AB, Foster E, Kuehl K, et al. Congenital heart disease in the older adult: a scientific statement from the American Heart Association. JAMA Pediatrics. 2020;174(5):467–475. doi:10.1001/jamapediatrics.2020.0108

7. Bixler GM, Powers GC, Clark RH, et al. Development of a bedside sonographic assessment protocol for pulmonary hypertension in neonates. Critical Care Medicine. 2017;45(1):e40–e47. doi:10.1097/CCM.0000000000002083

8. Carvalho, J.S., et al. (2023), ISUOG Practice Guidelines (updated): fetal cardiac screening. Ultrasound Obstet Gynecol, 61: 788-803.

9. Donofrio MT, Moon-Grady AJ, Hornberger LK, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation. 2014;129(21):2183–2242. doi:10.1161/01.cir.0000437597.44550.5d

10. EUROCAT. Prevalence charts and tables for congenital heart defects 2011–2018[Website]. European Commission - European Platform on Rare Disease Registration; 2020[updated 29/09/2020; cited October 2020].

11. Ganieva U, Alimdjanov I, Ganieva M, Abdunazarov T. Drug use in children hospitalized with cardio-rheumatologic diseases in Andijan, Uzbekistan: a cross-sectional descriptive study. BMC Pharmacol Toxicol. 2016 Feb 25;17:11. doi: 10.1186/s40360-016-0051-3. PMID: 26916198; PMCID: PMC4766618.

12. Gill HK, Splitt M, Sharland GK, et al. Patterns of recurrence of congenital heart disease: an analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography. Journal of the American College of Cardiology. 2020;75(8):911–921. doi:10.1016/j.jacc.2019.12.048

13. Grävinghoff LM, Wiegand G, Bertram H, et al. Outcome of prenatally diagnosed tetralogy of Fallot. Cardiology in the Young. 2019;29(1):26–33. doi:10.1017/S1047951118001999

14. Hoffman JI, Kaplan S. The incidence of congenital heart disease. Journal of the American College of Cardiology. 2002;39(12):1890–1900. doi:10.1016/S0735-1097(02)01886-7

15. Holland BJ, Myers JA, Woods CR Jr. Prenatal diagnosis of critical congenital heart disease reduces risk of death from cardiovascular compromise prior to planned neonatal cardiac surgery: a meta-analysis. Ultrasound Obstet Gynecol 2015; 45: 631–638

16. Lai WW, Geva T, Shirali GS, et al. Guidelines and standards for performance of a pediatric echocardiogram. Journal of the American Society of Echocardiography. 2016;19(12):1413–1430. doi:10.1016/j.echo.2006.09.001

17. Lopez L, Colan S, Stylianou M, et al. Relationship of echocardiographic Z scores adjusted for body surface area to age, sex, race, and ethnicity. Journal of the American Society of Echocardiography. 2020;33(2):e28. doi:10.1016/j.echo.2019.09.012

18. Lu JC, Ghadimi Mahani M, Krishnamurthy R, et al. Imaging of the right ventricle. Pediatric Cardiology. 2022;43(4):741–762. doi:10.1007/s00246-022-02879-x

19. Mahle WT, Martin GR, Beekman RH III, et al. Endorsement of Health and Human Services recommendation for pulse oximetry screening for critical congenital heart disease. Pediatrics. 2022;149(1):e2021054069. doi:10.1542/peds.2021-054069

20. Mertens L, Seri I, Marek J, et al. Targeted neonatal echocardiography in the neonatal intensive care unit. Journal of the American Society of Echocardiography. 2017;24(8):827–843. doi:10.1016/j.echo.2011.07.014

21. Mozumdar N, Rowland J, Pan S, Rajagopal H, Geiger MK, Srivastava S, Stern KWD. Diagnostic accuracy of fetal echocardiography in congenital heart disease. J Am Soc Echocardiogr 2020; 33: 1384–1390.

22. Mubayed L, Al-Kindi S. Recent Trends in Infant Mortality due to Congenital Heart Disease in the United States. Pediatrics 2019;144:344-44

23. Nayak K, Chandra G S N, Shetty R, Narayan PK. Evaluation of fetal echocardiography as a routine antenatal screening tool for detection of congenital heart disease. Cardiovasc Diagn Ther. 2016 Feb; 6(1):44-9. doi: 10.3978/j.issn.2223-3652.2015.12.01. PMID: 26885491; PMCID: PMC4731580.

24. Nyang M, Makalo L, Adegoke SA. A retrospective study on the prevalence, management, and outcomes of congenital heart diseases in children at Edward Francis small teaching hospital, banjul, the Gambia. BMC Cardiovasc Disord. 2025 Jul 23;25(1):539. doi: 10.1186/s12872-025-04948-6. PMID: 40702444; PMCID: PMC12288220.

25. Øyen N, Diaz LJ, Leirgul E, et al. Prepregnancy diabetes and offspring risk of congenital heart disease. Circulation. 2016;133(23):2243–2253. doi:10.1161/CIRCULATIONAHA.115.017465

26. Public Health England. National Congenital Anomaly and Rare Disease Registration Service: Congenital Anomaly Statistics 2018. Public Health England:London, UK, 2020

27. Salomon LJ, Alfirevic Z, Da Silva Costa F, et al. ISUOG Practice Guidelines: ultrasound assessment of fetal biophysical profile. Ultrasound in Obstetrics and Gynecology. 2019;54(1):17–30. doi:10.1002/uog.20145

28. Sayasathid J, Sukonpan K, Somboonna N. Epidemiology and Etiology of Congenital Heart Diseases. InTechOpen. 2012.

29. Simpson JM. Impact of prenatal diagnosis in hypoplastic left heart syndrome. Heart. 2022;108(3):180–187. doi:10.1136/heartjnl-2021-319044

30. Singh Y, Tissot C, Fraga MV, et al. Integrated cardiopulmonary sonography in the NICU: practical approach. JACC: Cardiovascular Imaging. 2023; 16(1):21–35. doi:10.1016/j.jcmg. 2022.09.004

31. Stevenson JG. Transesophageal echocardiography in patients with congenital heart disease: indications and limitations. Cardiology in the Young. 2016;26(6):1048–1061. doi:10.1017/S1047951116001906

32. Suluba E et al. Congenital heart diseases: genetics, non-inherited risk factors, and signaling pathways. Egypt J Med Hum Genet. 2020.

33. Turan S, Turan OM, Maisel P, et al. Prenatal diagnosis of d-transposition of the great arteries. Prenatal Diagnosis. 2018;38(7):514–520. doi:10.1002/pd.5243

34. WHO. Congenital anomalies: global report. Geneva: World Health Organization; 2020. Available at: https://www.who.int/publications/i/item/9789240017504

35. Zhao L., Chen L., Yang T. et al. Birth prevalence of congenital heart disease in China, 1980-2019: a systematic review and meta-analysis of 617 studies // Eur J Epidemiol. 2020. Vol. 35. P. 631-642.

36. Zidere V, Bellsham-Revell H, Vigneswaran TV, et al. Comparison of echocardiographic findings and cardiovascular outcome in fetuses at 14 weeks gestation versus second trimester. Prenatal Diagnosis. 2021;41(3):328–335. doi:10.1002/pd.5872

37. Zimmerman M.S., Smith A.G.C., Sable C.A. et al. Global, regional, and national burden of congenital heart disease, 1990-2017 // Pediatr Cardiol. 2020. Vol. 41. P. 571-597.